0001209191-21-001653.txt : 20210105 0001209191-21-001653.hdr.sgml : 20210105 20210105194334 ACCESSION NUMBER: 0001209191-21-001653 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20201231 FILED AS OF DATE: 20210105 DATE AS OF CHANGE: 20210105 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Quimi Daphne CENTRAL INDEX KEY: 0001543031 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-33497 FILM NUMBER: 21508325 MAIL ADDRESS: STREET 1: C/O AMICUS THERAPEUTICS, INC. STREET 2: 1 CEDAR BROOK DRIVE CITY: CRANBURY STATE: NJ ZIP: 08512 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: AMICUS THERAPEUTICS, INC. CENTRAL INDEX KEY: 0001178879 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 200422823 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1 CEDAR BROOK DRIVE CITY: CRANBURY STATE: NJ ZIP: 08512 BUSINESS PHONE: (609) 662-2000 MAIL ADDRESS: STREET 1: 1 CEDAR BROOK DRIVE CITY: CRANBURY STATE: NJ ZIP: 08512 FORMER COMPANY: FORMER CONFORMED NAME: AMICUS THERAPEUTICS INC DATE OF NAME CHANGE: 20020729 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2020-12-31 0 0001178879 AMICUS THERAPEUTICS, INC. FOLD 0001543031 Quimi Daphne C/O AMICUS THERAPEUTICS 1 CEDAR BROOK DRIVE CRANBURY NJ 08512 0 1 0 0 Chief Financial Officer Common Stock 2020-12-31 4 F 0 2620 23.09 D 241724 D Common Stock 2021-01-02 4 F 0 15164 23.09 D 226560 D Common Stock 2021-01-03 4 F 0 5053 23.09 D 221507 D Common Stock 2021-01-04 4 A 0 33131 A 254638 D Stock Options (right to buy) 21.78 2021-01-04 4 A 0 53355 0.00 A 2031-01-04 Common Stock 53355 53355 D Granted in the form of Restricted Stock Units. Each Restricted Stock Unit represents a contingent right to receive one share of Amicus common stock. The Restricted Stock Units will vest in four equal annual installments beginning on January 4, 2022. These options vest and become exercisable in a series of installments over a four year period with 25% vesting one year after the date of grant and the remaining 75% vesting ratably each month thereafter. /s/ Christian Formica, Attorney-in-Fact 2021-01-05